Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial |
Reference |
Staphylococcus aureus (ATCC 29213) |
- |
- |
3000 - ? |
Naringin |
1247 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
5000 - ? |
Reserpine |
1033 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
5600 - ? |
Rosmarinus officinalis (Essential oil) |
1352 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
5600 - ? |
Salvia officinalis (Essential oil) |
1352 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
6250 - ? |
Eucalyptus globulus (Crude extract) |
544 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
22400 - ? |
Triacetin |
1352 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
? - 0.2 |
Gentamicin (Gentamycin, Garamycin) |
68 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
? - 0.8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
68 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
? - 62.5 |
Cefoperazone/Sulbactam |
411 |
Staphylococcus aureus (ATCC 2943) |
- |
- |
50 - ? |
Ampicillin (Omnipen) |
137 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant + ESBL) |
- |
- |
>32 - ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
1055 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant + ESBL) |
- |
- |
>256 - ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1055 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
≤0.016 - ? |
Triclosan |
186 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
0.25 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1579 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
0.25 - ? |
Vancomycin (Vancocyn, Lyphocin) |
186 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
1 - 2 |
A-80915A |
1001 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
1 - ? |
Telavancin (TD-6424, Vibativ) |
209 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
1 - ? |
Vancomycin (Vancocyn, Lyphocin) |
1502 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
2 - ? |
A-80915B |
1001 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
269 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
2 - ? |
Vancomycin (Vancocyn, Lyphocin) |
269 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
8 - 16 |
Amikacin (Amikin) |
1502 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
8 - ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
186 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
16 - 32 |
Pexiganan |
14 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
64 - ? |
Nafcillin (Unipen, Nafcil) |
269 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
125 - ? |
Neomycin B |
1502 |
Staphylococcus aureus (ATCC 33591 + methicillin-susceptible) |
- |
- |
<0.016 - ? |
NB2001 |
186 |
Staphylococcus aureus (ATCC 33591) |
- |
- |
0.25 - ? |
TR-700 |
615 |